Cleared Traditional

Camber Sacroiliac (SI) Fixation System (K203503) - FDA 510(k) Clearance

Class II Orthopedic device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 2022
Decision
641d
Days
Class 2
Risk

K203503 is an FDA 510(k) clearance for the Camber Sacroiliac (SI) Fixation System. Classified as Sacroiliac Joint Fixation (product code OUR), Class II - Special Controls.

Submitted by Camber Spine Technologies, LLC (King Of Prussia, US). The FDA issued a Cleared decision on September 2, 2022 after a review of 641 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3040 - the FDA orthopedic device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Orthopedic submissions.

View all Camber Spine Technologies, LLC devices

Submission Details

510(k) Number K203503 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 30, 2020
Decision Date September 02, 2022
Days to Decision 641 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
519d slower than avg
Panel avg: 122d · This submission: 641d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code OUR Sacroiliac Joint Fixation
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 888.3040
Definition Sacroiliac Joint Fusion
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Orthopedic devices follow this clearance model.

Regulatory Consultant

MRC Global
Christine Scifert

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - OUR Sacroiliac Joint Fixation

All 99
Devices cleared under the same product code (OUR) and FDA review panel - the closest regulatory comparables to K203503.
SILO TFX MIS Sacroiliac Joint Fixation System
K221047 · Aurora Spine, Inc. · Oct 2022
iFuse TORQ® Implant System
K222605 · SI-BONE, Inc. · Sep 2022
Integrity-SI Fusion System
K222512 · OsteoCentric Technologies · Sep 2022
TransLoc 3D
K211496 · Foundation Fusion Solutions, LLC (Dba Cornerloc) · Jul 2022
ZESPIN SI Joint Fusion System, Paeon Posterior Cervical Fixation System, Paeon Anterior Cervical Plate System, Spinema Lumbar Plate System
K221050 · Aegis Spine, Inc. · Jun 2022
T-FIX® 3DSI Joint Fusion System
K214123 · Cutting Edge Spine, LLC · Jun 2022